Literature DB >> 32497905

Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.

Ryusuke Ae1, Joseph Y Abrams2, Ryan A Maddox2, Lawrence B Schonberger2, Yosikazu Nakamura3, Masanari Kuwabara3, Nobuko Makino3, Yuri Matsubara3, Daisuke Matsubara4, Koki Kosami3, Teppei Sasahara3, Ermias D Belay2.   

Abstract

BACKGROUND: Previous studies demonstrated that coronary artery lesions (CALs) resulting from Kawasaki disease (KD) can improve over time. However, limited information is available on sub-acute outcomes of CALs detected at admission during KD illness.
METHODS: The nationwide Japanese KD survey contained substantial information on KD patients with CALs detected at admission and who received standard IVIG treatment within 10 days of disease onset. Coronary outcomes were evaluated by changes in CALs from admission to the first assessment at 30 days from disease onset in three categories: improved, unchanged, and progressed. Ordinal logistic regression analysis was performed to evaluate factors associated with the outcomes.
RESULTS: Of 2024 patients with CALs detected at admission, improved, unchanged, and progressed outcomes were found in 1548 (76.5%), 390 (19.3%), and 86 (4.2%), respectively. Over 80% of patients with coronary artery (CA) dilatations had improved outcome. Independent factors associated with worse outcomes were larger-size CALs (adjusted ORs [95% CIs]: CA aneurysm = 5.13 [3.65-7.22] and giant CA aneurysms = 7.49 [3.56-15.72] compared with CA dilatation, respectively), age ≥ 60 months (1.45 [1.08-1.94] compared with 12-59 months), recurrent KD (1.57 [1.07-2.29]), parental history of KD (2.23 [1.02-4.85]), and delayed admission (8-10 days from disease onset: 1.76 [1.21-2.57] compared with 1-4 days).
CONCLUSIONS: KD patients with larger CALs, ≥60 months old, and with recurrent status or parental history may require more rigorous treatment. In addition, delayed admission may result in worse coronary outcome, indicating that prompt diagnosis and treatment are required.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32497905     DOI: 10.1016/j.ahj.2020.04.019

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.

Authors:  Ryusuke Ae; Hiroya Masuda; Taka-Aki Koshimizu; Masami Matsumura; Koki Kosami; Kanako Hayashida; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2021-03-08       Impact factor: 1.655

2.  Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Koki Kosami; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

3.  Differences in Sensitivity Between the Japanese and Z Score Criteria for Detecting Coronary Artery Abnormalities Resulting from Kawasaki Disease.

Authors:  Ryusuke Ae; Yoshihide Shibata; Tohru Kobayashi; Koki Kosami; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Hiroya Masuda; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2022-09-19       Impact factor: 1.838

4.  Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Authors:  Arthur J Chang; Sarah Baron; Jonathon Hoffman; Mark D Hicar
Journal:  Mol Immunol       Date:  2022-03-15       Impact factor: 4.174

5.  A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand.

Authors:  Kanokvalee Santimahakullert; Chodchanok Vijarnsorn; Yuttapong Wongswadiwat; Prakul Chanthong; Sappaya Khrongsrattha; Manat Panamonta; Paradorn Chan-On; Kritvikrom Durongpisitkul; Paweena Chungsomprasong; Supaluck Kanjanauthai; Jarupim Soongswang
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

6.  Myocardial Infarction in Children after COVID-19 and Risk Factors for Thrombosis.

Authors:  Eliza Cinteză; Cristiana Voicu; Cristina Filip; Mihnea Ioniță; Monica Popescu; Mihaela Bălgrădean; Alin Nicolescu; Hiyam Mahmoud
Journal:  Diagnostics (Basel)       Date:  2022-04-01

7.  Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.

Authors:  Yuhan Xia; Huixian Qiu; Zhengwang Wen; Hongying Shi; Huan Yu; Jie Li; Qihao Zhang; Jianjie Wang; Xing Rong; Rongzhou Wu; Maoping Chu
Journal:  Front Pediatr       Date:  2022-09-14       Impact factor: 3.569

8.  Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.

Authors:  Jie Liu; Qiaoyu Yue; Suyuan Qin; Danyan Su; Bingbing Ye; Yusheng Pang
Journal:  Front Cardiovasc Med       Date:  2022-09-09

9.  Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Masami Matsumura; Koki Kosami; Kanako Hayashida; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2021-08-07       Impact factor: 2.980

10.  A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Authors:  Wei Li; Xiufang He; Li Zhang; Zhouping Wang; Yanfei Wang; Huimei Lin; Jia Yuan; Xiaofei Xie; Youzhen Qin; Ping Huang
Journal:  Cardiovasc Ther       Date:  2021-06-18       Impact factor: 3.023

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.